| Literature DB >> 11858991 |
Peter S Dragovich1, Thomas J Prins, Ru Zhou, Theodore O Johnson, Edward L Brown, Fausto C Maldonado, Shella A Fuhrman, Leora S Zalman, Amy K Patick, David A Matthews, Xinjun Hou, James W Meador, Rose Ann Ferre, Stephen T Worland.
Abstract
The structure-based design, chemical synthesis, and biological evaluation of bicyclic 2-pyridone-containing human rhinovirus (HRV) 3C protease (3CP) inhibitors are described. An optimized compound is shown to exhibit antiviral activity when tested against a variety of HRV serotypes (EC(50)'s ranging from 0.037 to 0.162 microM).Entities:
Mesh:
Substances:
Year: 2002 PMID: 11858991 DOI: 10.1016/s0960-894x(02)00008-2
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823